Luigi Leo

491 total citations
10 papers, 284 citations indexed

About

Luigi Leo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Luigi Leo has authored 10 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Genetics. Recurrent topics in Luigi Leo's work include Cancer Treatment and Pharmacology (4 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers) and HER2/EGFR in Cancer Research (2 papers). Luigi Leo is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers) and HER2/EGFR in Cancer Research (2 papers). Luigi Leo collaborates with scholars based in Italy, France and Germany. Luigi Leo's co-authors include Liliana Montella, Raffaele Addeo, Gregorio Cennamo, Salvatore Del Prete, Michele Caraglia, Vincenzo Faiola, Claudio De Felice, Paolo Toti, Pietro Luzi and Karin Schürfeld and has published in prestigious journals such as Cancer, Thrombosis and Haemostasis and Human Pathology.

In The Last Decade

Luigi Leo

10 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luigi Leo Italy 6 149 131 71 46 45 10 284
Audrey Rhee United States 9 112 0.8× 55 0.4× 15 0.2× 21 0.5× 78 1.7× 28 299
Maryam Kadivar Iran 12 91 0.6× 121 0.9× 42 0.6× 9 0.2× 32 0.7× 40 341
Raymond Bélanger Canada 10 193 1.3× 119 0.9× 26 0.4× 38 0.8× 19 0.4× 15 350
F Cavalli Switzerland 11 63 0.4× 154 1.2× 28 0.4× 81 1.8× 18 0.4× 42 366
Alton V. Hallum United States 14 155 1.0× 88 0.7× 65 0.9× 23 0.5× 10 0.2× 25 677
Ulla Martinsson Sweden 10 54 0.4× 92 0.7× 18 0.3× 108 2.3× 97 2.2× 24 302
Kemal Beksaç Türkiye 10 52 0.3× 65 0.5× 30 0.4× 5 0.1× 35 0.8× 37 279
Linda Evans United Kingdom 6 146 1.0× 165 1.3× 15 0.2× 23 0.5× 43 1.0× 10 372
Huien Wang China 9 96 0.6× 207 1.6× 28 0.4× 4 0.1× 27 0.6× 12 329
Ahmet Murat Aydın United States 13 104 0.7× 91 0.7× 52 0.7× 3 0.1× 44 1.0× 50 417

Countries citing papers authored by Luigi Leo

Since Specialization
Citations

This map shows the geographic impact of Luigi Leo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Leo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Leo more than expected).

Fields of papers citing papers by Luigi Leo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Leo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Leo. The network helps show where Luigi Leo may publish in the future.

Co-authorship network of co-authors of Luigi Leo

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Leo. A scholar is included among the top collaborators of Luigi Leo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Leo. Luigi Leo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Tourneau, Christophe Le, Massimo Ghiani, M.C. Cau, et al.. (2023). First‐line cetuximab + platinum‐based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real‐world observational study—ENCORE. Cancer Reports. 6(5). e1804–e1804. 4 indexed citations
2.
Puglisi, Fabio, Giancarlo Bisagni, Mariangela Ciccarese, et al.. (2016). A Delphi Consensus and Open Debate on the Role of First-Line Bevacizumab for HER2-Negative Metastatic Breast Cancer. Future Oncology. 12(22). 2589–2602. 5 indexed citations
3.
Prete, Salvatore Del, Gregorio Cennamo, Luigi Leo, et al.. (2016). Adherence and Safety of Regorafenib for Patients with Metastatic Colorectal Cancer: Observational Real-Life Study. Future Oncology. 13(5). 415–423. 17 indexed citations
4.
Leo, Luigi, et al.. (2015). Response to eribulin in a difficult-to-treat, heavily pretreated breast cancer patient: a case report. Future Oncology. 11(sup15). 27–30. 1 indexed citations
5.
Addeo, Raffaele, Alessandro Sgambato, Gregorio Cennamo, et al.. (2010). Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer. Clinical Breast Cancer. 10(4). 301–306. 64 indexed citations
6.
Addeo, Raffaele, Vincenzo Faiola, Luigi Leo, et al.. (2008). Phase 2 trial of temozolomide using protracted low‐dose and whole‐brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases. Cancer. 113(9). 2524–2531. 69 indexed citations
7.
Bozzo, Maddalena, et al.. (2001). HELLP syndrome and factor V Leiden. European Journal of Obstetrics & Gynecology and Reproductive Biology. 95(1). 55–58. 10 indexed citations
8.
Toti, Paolo, Claudio De Felice, Michela Stumpo, et al.. (2000). Acute thymic involution in fetuses and neonates with chorioamnionitis. Human Pathology. 31(9). 1121–1128. 104 indexed citations
9.
Felice, Claudio De, Paolo Toti, Luigi Leo, et al.. (1997). Significance of Subclinical Histologic Chorioamnionitis 45. Pediatric Research. 42(3). 392–392. 1 indexed citations
10.
Peyvandi, Flora, et al.. (1996). Autoimmune Protein S Deficiency and Deep Vein Thrombosis after Chickenpox. Thrombosis and Haemostasis. 75(1). 212–213. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026